Back to Journals » OncoTargets and Therapy

PubMed
SJR OA
CiteScore
Impact Factor

OncoTargets and Therapy

COPE logo
ISSN: 1178-6930

Journal Image

Editor-in-Chief: Professor Gaetano Romano

OncoTargets and Therapy is an international, peer-reviewed journal focusing on the molecular diagnosis of and targeted molecular or precision therapy for all types of cancer. This journal explores the evidence behind new and existing therapies to aid their informed acceptance by clinicians and treatment adherence by patients.

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).

This journal offers Accelerated Publication.

Articles:

Latest articles:

- 5 records -

Review

Mechanisms and Emerging Strategies to Overcome Immunotherapy Resistance in Cold Tumours of Colorectal Cancer

Zhu X, Ge B, Wen L

OncoTargets and Therapy 2026, 19:621109

Published Date: 15 June 2026

Review

Bladder-Preserving Platforms for BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer

Zhang K, Ren Y

OncoTargets and Therapy 2026, 19:614003

Published Date: 15 June 2026

Original Research

A Nomogram Integrating HOXA9 Expression and Clinicopathological Factors for Predicting Postoperative Recurrence in Gastric Cancer: A Single-Center Retrospective Study

Weng J, Ying J, Xia M, Xie Y

OncoTargets and Therapy 2026, 19:596270

Published Date: 6 June 2026

Case report

Acquired BRAF-AGK Fusion Following Osimertinib Plus Savolitinib in EGFR-Mutated MET-Amplified Non-Small-Cell Lung Cancer: Durable Response to Gefitinib and Trametinib in a Case Report

Lee AF, Wu SY

OncoTargets and Therapy 2026, 19:605699

Published Date: 3 June 2026

Review

Efficacy and Safety of Regorafenib with or without Immune Checkpoint Inhibitors as Second-Line Treatment for Advanced Hepatocellular Carcinoma: A Systematic Review and Arm-Level Synthesis of Real-World Comparative Cohorts

Yu X, Zan H, Deng W, He R

OncoTargets and Therapy 2026, 19:606160

Published Date: 19 May 2026


Read more articles